Análisis de la acción Crown Reserve Acquisition Corp. I (CRAC)

Análisis de IA of Crown Reserve Acquisition Corp. I (CRAC)

Mantener

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.

Métricas de valoración

El PER previsto actual de Crown Reserve Acquisition Corp. I (CRAC) es 0.00, frente a su media de 5 años de .

PER previsto

Media 5A P/E

P/E actual

0.00

EV/EBITDA previsto

Media 5A EV/EBITDA

EV/EBITDA actual

0.00

Precio/ventas previsto

Media 5A P/S

P/S actual

0.00

Ballenas con CRAC en cartera

W

W. R. Berkley Corporation

+ Con en carteraCRAC

-1.34%

Rentabilidad a 3 meses

P

Polar Asset Management Partners Inc.

+ Con en carteraCRAC

-2.91%

Rentabilidad a 3 meses

Preguntas frecuentes sobre CRAC, respondidas por Alphio AI

Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.